Paasa Logo
Xencor, Inc. logo
XNCRNASDAQMarket closedOpens 9:30am ET

Xencor, Inc.

$25.00Last updated
-$0.60 (2.34%)Past day
Timezone

Xencor, Inc. (NASDAQ: XNCR) is trading at $25.00, about ₹2,402 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 2.34% today. Indian residents can buy Xencor from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$25.85
Previous close:$25.60
Volume:1.62M

Today's low

$24.62

Today's high

$25.98

52 week low

$10.38

52 week high

$30.61

XNCR opened at $25.85, closed previously at $25.60, and has traded between $10.38 and $30.61 over the past 52 weeks.

About

Xencor Inc., a biopharmaceutical firm headquartered in Monrovia, California, and established in 1997, operates as a clinical-stage entity. Its central mission involves the discovery and sophisticated engineering of monoclonal antibody and cytokine therapeutics, primarily aimed at treating patients afflicted with cancer and autoimmune disorders. The company is associated with several notable therapies currently in use, such as Sotrovimab, which targets the SARS-CoV-2 virus; Ultomiris, prescribed for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi, indicated for individuals with relapsed or refractory diffuse large B-cell lymphoma. Xencor maintains a robust and diverse pipeline of drug candidates advancing through various clinical trial stages. In oncology, this includes Plamotamab, a tumor-targeted antibody, currently undergoing Phase I trials for non-Hodgkin lymphoma; Vudalimab, a bispecific antibody in Phase II for metastatic castration-resistant prostate cancer and other solid tumor types; and Tidutamab, also in Phase II for neuroendocrine tumors. Further cancer-focused programs comprise XmAb306, XmAb104, and XmAb841, all in Phase I for selected solid tumors; AMG 509, in Phase I for prostate cancer; XmAb819, being developed for renal cell carcinoma; and a program involving Novartis XmAb. In the infectious disease arena, Xencor is progressing VIR-3434 through Phase II for hepatitis B virus infection; VIR-2482 in Phase 1/2 for influenza A; VIR-7832 in a Phase 1b/2a trial for mild-to-moderate COVID-19; and is involved in the Phase 2/3 NIH ACTIV-2 trial for COVID-19 with BMS-986414 + BMS-986413. Beyond these, the company is developing XmAb564, a Phase I candidate for autoimmune diseases; Obexelimab, also for autoimmune conditions; AIMab7195, designed to reduce IgE levels for allergic responses; and Xpro1595, an experimental treatment for Alzheimer's disease, mild cognitive impairment, and depression. Xencor also holds a licensing agreement with Caris Life Sciences.

Country
US
CEO
Bassil I. Dahiyat
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
260
Sector
Healthcare
IPO date
03/12/2013

Key statistics

Avg. volume

1.14M

Market cap

$1.85B

P/E Ratio

-11.52

Price-to-sales ratio

17.66

Enterprise value

$1.27B

Free cash flow yield

-12.16%

Debt-to-equity ratio

0.13

Return on equity

-14.46%

ROIC

-21.49%

Beta

0.88

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$125.58M

Earnings per share

-$1.24

Free cash flow

-$138.27M

Net profit margin

-155.59%

Gross margin

43.31%

EBITDA

-$46.98M

Revenue growth

13.65%

Similar securities

This is not an investment recommendation

How to buy Xencor from India

Indian residents can buy Xencor shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Xencor and place an order

    Find Xencor by name or by its ticker, XNCR, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Xencor trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Xencor position in USD and INR. Xencor pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Xencor from India

Trading and taxes when buying Xencor from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneXencor does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Xencor stock?

Yes. Xencor (XNCR) has been listed on NASDAQ since 2013, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Xencor share cost in rupees?

One Xencor share is $25.00 — about ₹2,402 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Xencor price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Xencor from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Xencor?

Yes. One Xencor share is $25.00, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Xencor.

How are gains on Xencor shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Xencor price. Paasa issues a capital-gains statement for your return.

Does Xencor pay a dividend?

No. Xencor does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Xencor from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Xencor shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Xencor shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Xencor holding, its cost and its closing value.

How do I sell Xencor and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.